During the past decade, Rose Research Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rose Research Center" #1 sponsor was "Rose Research Center, LLC" with 8 trials, followed by "Philip Morris Products S.A." with 2 trials sponsored, "Altria Client Services LLC" with 1 trials sponsored, "Embera NeuroTherapeutics, Inc." with 1 trials sponsored and "Friends Research Institute, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rose Research Center" #1 collaborator was "Foundation for a Smoke Free World INC" with 8 trials as a collaborator, "Rose Research Center, LLC" with 2 trials as a collaborator, "Embera NeuroTherapeutics, Inc." with 1 trials as a collaborator, "Food and Drug Administration (FDA)" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Rose Research Center" are "Smoking Cessation" (7 trials), "Cigarette Smoking" (4 trials), "Tobacco Use" (3 trials), "Tobacco Use Disorder" (3 trials) and "Harm Reduction" (2 trials). Many other conditions were trialed in "Rose Research Center" in a lesser frequency.

Most popular intervention types in "Rose Research Center" are "Drug" (9 trials) and "Other" (8 trials). Other intervention types were less common.

The name of intervention was led by "Bupropion" (2 trials), "Zonisamide" (2 trials), "CC" (1 trials), "Centanafadine" (1 trials) and "E-cigarette" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rose Research Center" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Rose Research Center". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Rose Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rose Research Center, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".